Shenzhen Bioeasy Biotechnology Co., Ltd. (SHE:300942)
China flag China · Delayed Price · Currency is CNY
6.70
-0.07 (-1.03%)
Sep 2, 2026, 3:04 PM CST

SHE:300942 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
461.19392.84293.4481.75247.45342.21
Short-Term Investments
----181.91-
Trading Asset Securities
122.97235.3302.92120.03-340.21
Cash & Short-Term Investments
584.16628.13596.31601.78429.36682.42
Cash Growth
8.84%5.34%-0.91%40.16%-37.08%80.01%
Accounts Receivable
115.99111.3394.1176.284.0397.37
Other Receivables
4.860.72.123.3615.176.5
Receivables
120.85112.0496.2379.5699.2103.87
Inventory
64.7654.7740.4331.46100.6193.86
Other Current Assets
24.2922.8718.6424.8745.2517.49
Total Current Assets
794.06817.81751.62737.67674.42897.64
Property, Plant & Equipment
568.44578.27562.9426.52324.64143.44
Long-Term Investments
69.0183.52100.69145.18195.7621.94
Other Intangible Assets
36.3837.3539.2441.3942.442.6
Long-Term Accounts Receivable
----3.61-
Long-Term Deferred Tax Assets
11.857.050.083.0614.97.4
Long-Term Deferred Charges
0.450.541.681.9314.311.42
Other Long-Term Assets
--0.960.5912.4228.07
Total Assets
1,4801,5251,4571,3561,2821,153

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
45.8772.9658.7677.3565.1155.66
Accrued Expenses
18.2626.223.0823.9439.4546.73
Short-Term Debt
1121----
Current Portion of Long-Term Debt
14.4213.5541.65.475.18-
Current Portion of Leases
---9.2818.614
Current Income Taxes Payable
1.174.550.050.010.019.74
Current Unearned Revenue
20.9917.2525.118.6566.6127.59
Other Current Liabilities
8.415.23.362.224.822.91
Total Current Liabilities
120.11160.7151.96136.93199.78156.63
Long-Term Debt
438.23413426.39345.7856.32-
Long-Term Leases
---5.3439.2527.12
Long-Term Unearned Revenue
39.3241.096.516.5420.3322.19
Other Long-Term Liabilities
2.082.082.083.022.08-
Total Liabilities
599.74616.87586.92507.61317.75205.94

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
405.08405.07401.32400.86400.86400.86
Additional Paid-In Capital
221.64221.56190.22186.59178.7141.91
Retained Earnings
186.18215.89209.14192.02385.43402.28
Comprehensive Income & Other
61.161.5668.3369.52-0.09-0.28
Total Common Equity
874904.08869.01848.99964.89944.76
Minority Interest
6.453.61.24-0.27-0.191.82
Shareholders' Equity
880.45907.68870.24848.73964.7946.58
Total Liabilities & Equity
1,4801,5251,4571,3561,2821,153

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
463.65447.55467.98365.87119.3441.12
Net Cash (Debt)
120.51180.59128.33235.91310.02641.31
Net Cash Growth
37.03%40.72%-45.60%-23.91%-51.66%69.17%
Net Cash Per Share
0.260.390.300.590.781.63
Filing Date Shares Outstanding
404.63405.07401.32400.86400.86400.86
Total Common Shares Outstanding
404.63405.07401.32400.86400.86400.86
Working Capital
673.95657.11599.66600.74474.64741.02
Book Value Per Share
2.162.232.172.122.412.36
Tangible Book Value
837.62866.73829.76807.6922.49902.16
Tangible Book Value Per Share
2.072.142.072.012.302.25
Buildings
-553.85330.0315.8715.8710.24
Machinery
-97.9187.0990.58106.5172.08
Construction In Progress
-2.26199.79356.63190.8751.34